CoChat

Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

The effects of d-amphetamine (0.5 mg/kg PO) on regional cerebral glucose utilization were measured with Positron Emission Tomography (PET). Subjects included ten chronic schizophrenics and six controls who received amphetamine, and six chronic schizophrenics and nine controls who received placebo or no treatment. Amphetamine decreased glucose metabolism in all regions studied (frontal, temporal, and striatal) in normal and schizophrenic subjects. The metabolic effects of amphetamine were correlated with plasma level of the drug. Cortical atrophy was associated with a blunted metabolic response.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf00177923

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

Items 101–107 of 107

Metadata

Authors
Wolkin, A., Angrist, B., Wolf, A., Brodie, J., Wolkin, B., Jaeger, J., Cancro, R., & Rotrosen, J.
Affiliations
  • United States Department of Veterans Affairs (US)
  • Brookhaven National Laboratory (US)
  • New York University (US)
  • Manhattan Psychiatric Center (US)
Venue
Psychopharmacology
Published
1987-06
Volume
92
Issue
2
Pages
241-6
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2011886002
Cited by
100
References
40
Citations by year
2020: 1 · 2019: 2 · 2018: 1 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
6.42
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service (15638)
  • National Institute of Mental Health (MH 35976)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
amphetamine, schizophrenia, regional cerebral glucose metabolism, d-amphetamine, cortical atrophy, striatum, frontal cortex, temporal cortex, plasma drug concentration, drug-induced metabolic effects
MeSH terms
Adult, Amphetamine, Brain, Brain Chemistry, Chronic Disease, Humans, Kinetics, Male, Middle Aged, Schizophrenia, Tomography, Emission-Computed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.